XML 18 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income $ 1,013 $ 4,763
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 35,942 33,266
Provision for bad debts 0 23,500
Equity in earnings of joint ventures (6,725) (4,922)
Distributions from joint ventures 7,083 3,993
Amortization of deferred financing costs and loan discount 1,949 1,636
(Gain) loss on sale and disposal of equipment (1,831) 408
Gain on sale of imaging centers 0 (2,301)
Stock-based compensation 4,890 4,314
Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in purchase transactions:    
Accounts receivable (7,113) (29,445)
Other current assets (568) 4,553
Other assets (900) (835)
Deferred taxes (78) 1,940
Deferred rent 1,788 1,830
Deferred revenue 153 445
Accounts payable, accrued expenses and other 11,345 7,014
Net cash provided by operating activities 46,948 50,159
CASH FLOWS FROM INVESTING ACTIVITIES    
Purchase of imaging facilities (14,094) (9,904)
Investment at cost (2,200) (500)
Purchase of property and equipment (45,133) (42,647)
Proceeds from sale of equipment 2,324 63
Proceeds from sale of imaging facilities 0 5,627
Cash distribution from new JV partner 0 1,473
Equity contributions in existing and purchase of interest in joint ventures (2,000) (80)
Net cash used in investing activities (61,103) (45,968)
CASH FLOWS FROM FINANCING ACTIVITIES    
Principal payments on notes and leases payable (3,393) (3,769)
Payments on Term Loan Debt (16,540) (12,125)
Distributions paid to noncontrolling interests (913) (655)
Deferred financing costs and debt discount 0 (570)
Proceeds from sale of noncontrolling interest, net of taxes 0 4,850
Contributions from noncontrolling partners 0 125
Proceeds from revolving credit facility 19,800 139,400
Payments on revolving credit facility (19,800) (139,400)
Net cash used in financing activities (20,846) (12,144)
EFFECT OF EXCHANGE RATE CHANGES ON CASH (69) 22
NET DECREASE IN CASH AND CASH EQUIVALENTS (35,070) (7,931)
CASH AND CASH EQUIVALENTS, beginning of period 51,322 20,638
CASH AND CASH EQUIVALENTS, end of period 16,252 12,707
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION    
Cash paid during the period for interest 17,509 19,023
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES    
Equipment and leasehold improvements not yet paid for 13,600 17,500
Capital lease debt incurred 4,000 5,200
Investment in joint venture, capital contribution 0 3,000
Fixed assets received $ 16,800 $ 0